StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Thursday. The firm issued a hold rating on the software maker’s stock.
Veradigm Price Performance
MDRX stock opened at $9.51 on Thursday. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $11.80. The firm has a fifty day moving average price of $9.98 and a 200 day moving average price of $9.73.
Hedge Funds Weigh In On Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- High-Flying HEICO Eyes New Heights in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Beyond Reality: Investing in AR/VR Tech for Future Gains
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
